JP Morgan Private Wealth Advisors’s Epizyme, Inc EPZM Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,243	Closed	-$179K	–	1404
2017 Q4	$179K	Hold	14,243	–	–	﹤0.01%	1200
2017 Q3	$271K	Sell	14,243 -1,613	-10%	-$24.6K	﹤0.01%	1052
2017 Q2	$239K	Hold	15,856	–	–	﹤0.01%	1090
2017 Q1	$272K	Hold	15,856	–	–	﹤0.01%	1107
2016 Q4	$192K	Hold	15,856	–	–	﹤0.01%	1171
2016 Q3	$156K	Hold	15,856	–	–	﹤0.01%	1167
2016 Q2	$162K	Hold	15,856	–	–	﹤0.01%	1178
2016 Q1	$192K	Hold	15,856	–	–	﹤0.01%	1088
2015 Q4	$254K	Hold	15,856	–	–	﹤0.01%	936
2015 Q3	$204K	Hold	15,856	–	–	﹤0.01%	934
2015 Q2	$381K	Hold	15,856	–	–	﹤0.01%	766
2015 Q1	$298K	Hold	15,856	–	–	﹤0.01%	893
2014 Q4	$299K	Hold	15,856	–	–	﹤0.01%	878
2014 Q3	$430K	Hold	15,856	–	–	0.01%	740
2014 Q2	$493K	Sell	15,856 -15,000	-49%	-$353K	0.01%	565
2014 Q1	$703K	Buy	+30,856	New	+$935K	0.01%	478

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

JP Morgan Private Wealth Advisors's EPZM Position: Q1 2018 in Review

JP Morgan Private Wealth Advisors sold out of Epizyme, Inc (EPZM) in Q1 2018, closing a stake of 14,243 shares — an estimated $179K sold.

JP Morgan Private Wealth Advisors first reported a position in EPZM in Q1 2014 and held it in 16 quarters. The position peaked at $703K in Q1 2014. 109 funds tracked by Wall St. Rank hold EPZM as of Q1 2018.

JP Morgan Private Wealth Advisors reported no remaining Epizyme, Inc position as of Q1 2018 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 14,243 Epizyme, Inc shares in Q1 2018, an estimated $179K.
JP Morgan Private Wealth Advisors first reported a position in Epizyme, Inc in Q1 2014 and held it in 16 quarters.
JP Morgan Private Wealth Advisors's Epizyme, Inc position peaked at $703K in Q1 2014.
109 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2018.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2018, filed 10 May 2018.